yttrium Y 90-labeled basiliximab: Clinical Trials

1 trial of yttrium Y 90-labeled basiliximab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow yttrium Y 90-labeled basiliximab: new trials by email Literature Review of yttrium Y 90-labeled basiliximab trials Research Report on yttrium Y 90-labeled basiliximab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma
basiliximab, carmustine, etoposide - Recurrent Adult Hodgkin Lymphoma
Phase 1CompletedCity of Hope Medical Center252013-02-132026-10-15

Conditions studied

Hodgkin Disease (1)

Sponsors

City of Hope Medical Center (1)

Countries

United States (1)

Top investigators

Eileen Smith (1)

Results publications

PMID 34638132

NIH funding

P01CA030206 (1), R21CA185875 (1)